Designed as a trial. Built to become evidence.
Our approach connects how a study is run with what it goes on to prove. Every protocol is written with the publication in mind, and every dataset is mined for everything it holds.
TrialEvidence
- Protocol
- 500+ sites
- Database lock
- Registries
- Publication
Rigour underneath. Business value on top.
The same rule applies in the clinic and in the analysis. Human expertise is the gold standard, AI is validated against it, and corroborating methods are reported as secondary. The science is rigorous first, and commercially useful because of it.
Commercial value
Positioning, reach, market advantage
AI, validated against experts
SIROai adds depth, never the final word
Human expertise, the gold standard
Investigators, statisticians, medical and writing teams
Patient conversation, decoded at scale.
We decode patient conversation and build that understanding into how a study is shaped and how a molecule is positioned.
- English
- Hindi
- Hinglish
- What it is
- Commercial and reputational intelligence, a parallel evidence stream that sharpens strategy.
- What it is not
- Regulatory-grade evidence. We never present it as such.
The analytical depth of SIROai.The clinical reach of SIRO Clintech.
One evidence partner.
Starting a trial, or sitting on data?
Either way, tell us what the molecule needs to prove.
Partner with us